Home / Who we are
 |
About MAI CDMO NetworkAt MAI CDMO Network, we help pharmaceutical and biotech companies sort through the complexities of drug development by connecting them with the right contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs). Our mission and vision guide us in our commitment to innovation and collaboration. |
Our MissionTransforming the CMO/CDMO market by providing an efficient and user-friendly platform that connects these companies with the pharmaceutical industry. We aim to simplify and expedite the search and contracting process, allowing pharmaceutical companies and manufacturers to focus on what they do best: innovate and grow. We are committed to transparency, quality, and customer satisfaction in all our operations. |
 |
 |
The VisionTo be the world`s leading platform for connecting pharmaceutical projects with development and manufacturing solutions, driving innovation and growth in the sector. We see ourselves as an essential facilitator in the manufacturing ecosystem, helping companies achieve their goals more quickly and efficiently. Our vision is to create a world where finding and contracting the right CMO/CDMO is just one click away. |
Our Core Values
|
Join us at MAI CDMO whether you are a pharmaceutical or biotech company, or a contract manufacturer.
Let us help you achieve your project goals with confidence and efficiency. Together, we can accelerate the delivery of life-changing therapies to patients around the world.
Founder & co-CEO, Pharmacist
Founder & co-CEO, Engineer
Scientific advisor
2026-02-12
Beyond Capacity: How Smarter Science is Redefining Biologics Manufacturing
See more
2026-02-04
What truly matters when selecting a Contract Manufacturing Organization for clinical and commercial success
See more
2026-01-30
Regulatory expertise can be the difference between a smooth veterinary drug approval and costly delays.
See more
Adare Pharma is a global CDMO with sites in US and EU providing turnkey product development through commercial manufacturing expertise focused on oral dosage forms for the Pharmaceutical, Animal Health and OTC markets. Adare s proprietary technology platforms specialize in ODT s, taste masking and customized drug release.
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Human, Veterinary
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), Health Canada...
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
Accueil Sites Osny. Acquired in 2011, the Osny site specializes in the development and production of highly active solid pharmaceutical forms (hormonal and allergens). This 4,000 m2 pharmaceutical plant located 36 km northwest of Paris employs around a hundred people.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP), FDA (cGMP), ANVISA (Brazil B-GMP),...
Markets: FDA (USA), EMA (EU), PMDA (Japan), MHRA (UK), NMPA...
Tubilux Pharma: registered office; manufacturing facility
Activity: FDF / DRUG PRODUCTS, SERVICES manufacturing
Uses: Commercial (Phase IV), Human, Veterinary
Services: N/A
Batch Size / Reactor: Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP), TGA (Australia GMP),...
Markets: FDA (USA), EMA (EU), TGA (Australia), ANVISA...
Your cGMP-compliant CDMO for end-to-end services in the complex oral solids dosage forms field, based in Binzen Germany
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Development services, Manufacturing services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Cell Therapy company with excess Cleanroom capacity
Activity: FDF / DRUG PRODUCTS, BIOLOGICS, SERVICES manufacturing
Uses: Investigational, Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: EMA (EU GMP)
Markets: EMA (EU)
Fully integrated CDMO solutions for Blow-Fill-Seal (BFS), sterile multidose, non-sterile multi-dose, sachets, capsules and tablets.
Activity: FDF / DRUG PRODUCTS, PARTICLE ENGINEERING manufacturing
Uses: Commercial (Phase IV), Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP)
Markets: FDA (USA), EMA (EU)
Ophtalmic and Otic - Solutions, suspensions, emulsions, ointments and gels - FDA Approved facility
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Commercial (Phase IV), Human,...
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium, Large
Compliance: ISO, EMA (EU GMP), FDA (cGMP), World Health...
Markets: FDA (USA), EMA (EU)
Seda Pharmaceutical Development Services specialises in integrated Pharmaceutical Development and Clinical Pharmacology.
Activity: FDF / DRUG PRODUCTS manufacturing
Uses: Investigational, Human
Services: Regulatory services, Development services,...
Batch Size / Reactor: Small, Medium
Compliance: ECOVADIS, MHRA (UK GMP)
Markets: DIGEMID (Peru), COFEPRIS (Mexico), INVIMA...
MAI CDMO is a specialized B2B platform designed to assist pharmaceutical and biotechnology companies in navigating the complex landscape of drug development and manufacturing. Our platform is dedicated to facilitating connections between pharmaceutical firms and a diverse network of qualified contract development and manufacturing organizations (CDMOs) and contract manufacturing organizations (CMOs).
At MAI CDMO, we recognize the multifaceted challenges faced by pharmaceutical companies in bringing innovative therapies to market. Our mission is to simplify this process through our comprehensive platform, which serves as a bridge between your project requirements and the most suitable manufacturing partners.
Our services are structured to meet the specific needs of the pharmaceutical industry. Here are some key features:
Comprehensive CDMO and CMO Finder: Our user-friendly platform allows users to efficiently search for and compare a broad range of trusted CMOs and CDMOs, each with demonstrated expertise across various therapeutic areas and dosage forms.
Accelerated Clinical Trial Manufacturing: We facilitate the identification of organizations that meet your specific project requirements and timelines, thereby expediting the clinical trial process.
Cost Optimization: By streamlining the partner selection process, we enable you to focus on your core development activities while also helping you to optimize manufacturing costs.
MAI CDMO is not just a tool for pharmaceutical companies; we also offer valuable opportunities for CDMOs and CMOs to showcase their capabilities. Our platform is designed to enhance the visibility of these organizations to a targeted audience seeking reliable manufacturing partners.
By joining our network, CMOs and CDMOs can:
Increase Industry Visibility: Reach a broader pool of potential clients actively searching for partners with specific skills and experience.
Expand Client Acquisition: By displaying their expertise and past successes, organizations can secure new contracts and forge lasting partnerships within the pharmaceutical sector.
Streamlined Communication: Our platform offers integrated tools for initial contact, project inquiries, and contract negotiations, facilitating smoother collaboration between pharmaceutical companies and their partners.
MAI CDMO is committed to fostering a collaborative environment that encourages innovation and growth within the pharmaceutical development ecosystem. We believe that by connecting pharmaceutical companies with the most qualified CMOs and CDMOs, we can significantly accelerate the development of life-saving therapies for patients worldwide.
Our platform goes beyond merely connecting companies; we provide a suite of specialized services to ensure successful partnerships. These services include:
Expert Consulting Services: Our team offers free consultation to guide pharmaceutical companies through the CDMO/CMO selection process. We leverage our industry knowledge to help you identify partners who align with your project needs.
Data-Driven Insights: We provide valuable insights and analytics to help you understand market trends, supplier capabilities, and competitive pricing. This data empowers you to make informed decisions and foster successful partnerships.
Resources and Best Practices: Access a wealth of resources, including articles, case studies, and best practices, to navigate the intricacies of pharmaceutical outsourcing effectively.
Whether you`re a pharmaceutical company looking to streamline your drug development process or a CDMO seeking to enhance your market presence, MAI CDMO Network serves as your strategic partner. Our platform is designed to ensure efficient, effective connections that meet the unique demands of the pharmaceutical sector.
In today’s fast-paced pharmaceutical landscape, the ability to quickly find and engage with the right partners is crucial. MAI CDMO is here to provide that vital link. With our advanced tools and resources, you can navigate the complexities of pharmaceutical project development with confidence.
Let MAI CDMO help you achieve your pharmaceutical development goals. By connecting you with the right contract manufacturing organizations, we enable you to bring your life-saving therapies to market more efficiently.
Join us today and discover how our innovative platform can drive your success in the global pharmaceutical market.
If you have any questions or suggestions, click here. We will be happy to assist you.
